Related by context. All words. (Click for frequent words.) 69 DOS# 69 Topical Interferon Alpha 2b 65 Panzem 64 Marqibo TM 64 GLP toxicology studies 63 IL# PE#QQR 63 EP #R 63 Personalized Immunotherapy 63 nalbuphine ER 62 Zemiva TM 62 PLK1 SNALP 62 ApoB SNALP 62 novel anticancer 62 Azedra ™ 62 PORxin TM 62 OvaRex ® MAb 62 novel peptide 62 Bicifadine 61 PSMA ADC 61 CINTREDEKIN BESUDOTOX 61 LEP ETU 61 rhThrombin 61 PREOS 61 FOLOTYN ® 61 TELINTRA 61 KNS # 61 TOCOSOL Paclitaxel 61 Cintredekin Besudotox 61 YONDELIS 61 Surfaxin LS 61 Factor VIIa 60 HuLuc# 60 Allovectin 7 R 60 preclinical 60 Panzem R NCD 60 EndoTAG TM -1 60 Proxinium TM 60 pralatrexate 60 Chrysalin 60 elotuzumab 60 Azedra TM 60 mertansine 60 Insegia 60 IND submission 60 Onconase 60 MOZOBIL 60 epothilones 60 PXD# 60 Onalta ™ 60 HspE7 60 TKM ApoB 60 ALN VSP 60 Trofex TM 60 OvaRex R 60 CB2 selective receptor agonist 60 mitogen activated ERK kinase 60 PDE4 inhibitor 60 CoFactor 60 synthetic retinoid 60 TLK# 60 RGB # 60 Phase Ib study 60 AEG# 60 Trofex 60 targeted radiotherapeutic 59 Urocidin TM 59 QuadraSphere 59 tiapamil 59 MGCD# [001] 59 CCX# 59 UVIDEM 59 novel peptides 59 VitiGam 59 EFAPROXYN 59 triphendiol 59 radiotherapeutic 59 BCX# 59 selective androgen receptor modulators 59 Androxal TM 59 Solazed 59 KL4 surfactant 59 INCB# [001] 59 Dyloject TM 59 Allovectin 7 r 59 Panzem R 59 RECOTHROM R 59 DAVANAT R 59 Solazed TM 59 MyVax R 59 Phase IIb clinical trials 59 GAP #B# 59 OncoVEX 59 MAXY VII 59 IND enabling 59 orally dosed 59 RIGScan CR 59 PRT# 59 Stimuvax R 59 GRNVAC1 59 DAVANAT 59 RhuDex ® 59 AeroLEF TM 59 MAXY G# 59 inhibit KSP 59 LE SN# 59 IAP inhibitors 59 vinorelbine tartrate 59 PSN# [002] 59 targeted antifolate 59 adecatumumab 59 Hedgehog antagonist 59 phase IIa clinical 59 OncoVEX GM CSF 59 CR# vcMMAE 59 THR beta agonist 59 Atiprimod 59 punctal plug 59 SinuNase ™ 59 depsipeptide 59 Neo Kidney Augment 58 Bioral Amphotericin B. 58 BiTE antibody 58 IMA# 58 therapeutic monoclonal antibodies 58 Allovectin 7 ® 58 XL# XL# 58 Phase IIB 58 ThGRF 58 antiangiogenic 58 IRX 2 58 Cerashield 58 REOLYSIN ® 58 Exherin TM 58 Cloretazine ® 58 therapeutic monoclonal antibody 58 HCV protease inhibitors 58 pan HDAC inhibitor 58 PNP inhibitor 58 VALSTAR 58 Excellagen 58 XmAb# 58 SNALP technology 58 Neuradiab 58 huC# DM4 58 NEUMUNE 58 XP #L 58 BNC# 58 liposomal doxorubicin 58 PDX pralatrexate 58 BioVant 58 Junovan 58 Alocrest 58 histone deacetylase HDAC inhibitor 58 Poly ICR 58 cediranib 58 Myocet 58 CRMD# 58 preclinical studies 58 AAG geldanamycin analog 58 rxRNA 58 Radilex 58 DCVax R 58 hypoxia activated prodrug 58 Vicinium TM 58 EndoTAG TM 58 rPA anthrax vaccine 58 ALN PCS 58 peptide antigens 58 olaparib 58 AMPK activators 58 Archexin 58 Chemophase 58 hormone LHRH antagonist 58 LNP formulations 58 acyclovir Lauriad R 58 AVN# [001] 58 investigational humanized monoclonal antibody 58 RenaZorb TM 58 Desmoteplase 58 #ME# 58 nanopharmaceutical 58 pomalidomide 58 JAK inhibitor 58 Phase #b/#a clinical 58 reslizumab 58 biologic therapeutics 58 Sudhir Agrawal D.Phil 58 Octreotide 58 Virulizin R 58 brostallicin 58 TBC# 58 carbohydrate polymer 58 NB S# 58 lexidronam injection 58 APF# 58 siRNA therapeutic 58 Aerosurf 58 mifamurtide 57 Dalbavancin 57 HSP# inhibitor 57 plasma kallikrein inhibitor 57 PrevOnco 57 epothilone 57 Orathecin 57 Preclinical studies suggest 57 lucinactant 57 siRNA therapeutics 57 SNT MC# 57 OMP #M# 57 Protexia ® 57 Proellex TM 57 TELCYTA 57 HGS ETR1 57 LE DT 57 Zybrestat 57 Varespladib 57 tezampanel 57 Alzhemed TM 57 AQ4N 57 polymer platinate 57 microtubule inhibitor 57 GelSite R polymer 57 Saforis 57 CBLC# 57 Azedra 57 Genasense ® oblimersen 57 therapeutic peptide 57 trastuzumab DM1 T DM1 57 Protexia R 57 Cetrorelix 57 Novolimus 57 ALN TTR# 57 Panzem NCD 57 RSD# 57 Guanilib 57 Targeted Chemotherapy 57 Phase IIa clinical trials 57 peripherally acting 57 preclinical toxicology 57 Fibrillex TM 57 volociximab 57 NeoLipid R 57 histamine dihydrochloride 57 Excellarate 57 Levoleucovorin 57 E2F Decoy 57 DPX Survivac 57 Daclizumab 57 eniluracil 57 personalized immunotherapy 57 KRN# 57 Kamada AAT 57 SparVax TM 57 preclinically 57 ularitide 57 anticancer compound 57 lesinurad 57 Nasulin 57 Regado 57 proteasome inhibitor 57 immune modulatory 57 docetaxel Taxotere R 57 PEG PAL 57 PROCHYMAL 57 Veronate 57 cancer immunotherapies 57 cannabinor 57 CA4P 57 Romidepsin 57 neratinib 57 Asentar 57 Etubics 57 Aurexis 57 tubulin inhibitor 57 recombinant factor VIIa 57 ELACYT 57 prostone 57 molecular imaging radiopharmaceutical 57 BrachySil 57 Xanafide 57 Immunotherapeutic 57 adult mesenchymal stem 57 urocortin 2 57 Preos 57 Azedra TM Onalta TM 57 HepDirect 57 Interferon alpha 57 atacicept 57 Synavive 57 CCR9 antagonist 57 BAY #-# 57 Civacir 57 Curaxin 57 polyclonal antibody 57 BLA filing 57 XL# anticancer compounds 57 Bortezomib 57 ATL# [001] 57 LEUKINE 57 Cleviprex TM clevidipine 57 obatoclax 57 HQK 57 HepeX B 57 stable nucleic acid 57 TOCOSOL Camptothecin 57 investigational monoclonal antibody 57 MAGE A3 ASCI 57 PRECISE trial 57 CDP# 57 Shigamabs R 57 HGS# 57 GVAX ® 57 MEK inhibitor 57 MyVax ® 57 ZEVALIN ® 57 entinostat 57 registrational 57 Amigal 57 Mepact 57 Allovectin 7 56 lanreotide 56 Urocortin 2 56 initiate Phase 1b 56 HGS ETR2 56 Maxy G# 56 Viramidine 56 immunotherapeutic 56 oxymorphone ER 56 sorafenib tablets 56 deforolimus 56 SEPET TM 56 Onalta 56 torsemide ER 56 SARMs 56 Pimavanserin 56 PS# [001] 56 Fodosine 56 L MTP PE 56 vosaroxin 56 KineMed 56 tafamidis 56 GED aPC 56 tesmilifene 56 mesylate 56 Pharmos proprietary 56 orally bioavailable 56 DAVANAT ® 56 Anavex #-# 56 oral picoplatin 56 Trofex ™ 56 Emezine 56 Davanat 56 PEG SN# 56 allosteric modulator 56 BEMA TM Fentanyl 56 liprotamase 56 alvespimycin 56 Marqibo 56 OMNARIS HFA 56 Vilazodone 56 Zerenex 56 talactoferrin 56 PD LID 56 Phase Ib clinical 56 mitotic kinesins 56 Octreolin 56 metaglidasen 56 zileuton CR 56 NanoCrystal technology 56 IIa trial 56 Exelbine 56 Urokinase 56 liposomal delivery 56 Adnectin 56 HCV protease 56 Litx 56 Prednisporin 56 H#N# VLP vaccine 56 tolevamer 56 teduglutide 56 generation URAT1 inhibitor 56 IL# PE 56 indibulin 56 Aganocide 56 paclitaxel Taxol ® 56 Squalamine 56 Pyridorin 56 tanespimycin 56 Soliris eculizumab 56 radiation sensitizer 56 Anidulafungin 56 T Pred 56 GTC recombinant human 56 CD# CEA 56 Phase #/#a trial 56 ISTODAX 56 Bioral 56 ELADUR 56 TAFA# 56 Neulasta ® 56 Eligard R 56 TRANSDUR Sufentanil 56 Ascend Therapeutics 56 Plicera 56 nanoviricides 56 Thiovir 56 platinum chemotherapeutic 56 BrachySil TM 56 CORT # 56 LibiGel ® 56 ALK inhibitors 56 Chimigen TM 56 novel immunomodulatory 56 immunotherapeutics 56 oncolytic virus 56 virus HCV protease inhibitor 56 selective androgen receptor modulator 56 oral prodrug 56 Generx TM 56 Zingo TM 56 Onco TCS 56 Abbokinase 56 Theratope 56 GALNS 56 bafetinib 56 DXL# 56 ThermoDox R 56 bovine thrombin 56 PLX cells 56 isoform selective 56 pradefovir 56 Harbor BioSciences 56 BLA submission 56 Tezampanel 56 Liposomal 56 Temsirolimus 56 systemic RNAi 56 liposomal formulation 56 CytoFabTM 56 proprietary transdermal patch 56 HuMax CD4 56 Liprostin 56 sapacitabine 56 intravenous acetaminophen 56 HDL Mimetic Peptide 56 cintredekin besudotox 56 nonclinical studies 56 Glufosfamide 56 Phase #b/#a 56 Myrexis 56 eprotirome 56 OXi# 56 tezampanel NGX# 56 Amrubicin 56 GeneICE 56 Nexavar sorafenib 56 TKM PLK1 56 Aurora kinase inhibitor 56 MEK inhibitors 56 StaphVAX 56 Cloretazine R 56 AzaSite Plus 56 ART# 56 Phenoptin 56 RNAi therapeutic targeting 56 ganetespib 56 Hectorol R 56 OPAXIO 56 candidate AQ4N 56 faropenem 56 Adenosine Therapeutics 56 Nexavar ® 56 Alfacell proprietary ribonuclease 56 Trizytek 56 ENMD # 56 Sym# 56 lintuzumab 56 HCV protease inhibitor 56 enzastaurin 56 pharmacokinetic interactions 56 Aviptadil 56 Cloretazine R VNP#M 56 CYT# potent vascular disrupting 56 evaluating tivozanib 56 MYDICAR ® 56 IAP inhibitor 56 Cannabinor 56 Angiocept 56 Iluvien ® 56 Elvitegravir 56 Cellegesic 56 PCK# 56 Ampligen R 56 GATTEX 56 rALLy clinical trial 56 Symadex 56 GSK # 56 SinuNase TM 56 molecularly targeted 56 phase IIb clinical 56 investigational therapies 56 Psoraxine R 55 PEGylated 55 CEQ# 55 Intravenous CP 55 MYDICAR 55 Phase 2a clinical trials 55 SERMs 55 BiTE 55 Alinia 55 eTag assays 55 Menerba 55 incyclinide 55 TYZEKA 55 Pertuzumab 55 PDE# inhibitors 55 ARIKACE ™ 55 Tolevamer 55 otelixizumab 55 pharmacological chaperone 55 tumor specific antigen 55 Enhanze Technology 55 Oncaspar 55 Hsp# inhibitor 55 tranilast 55 Ampligen ® 55 romidepsin novel 55 Xcytrin R 55 APOPTONE 55 systemically administered 55 trastuzumab Herceptin R 55 Velcade bortezomib 55 HepaGam B 55 Amplimexon 55 Prednisporin TM 55 SUCCEED trial 55 XL# XL# XL# XL# 55 EVIZON TM squalamine lactate 55 Dasatinib 55 humanised monoclonal antibody 55 bardoxolone methyl 55 JAK2 inhibitor 55 uricase 55 antisense drug 55 Acapodene 55 TACI Ig 55 Triolex 55 candidate deforolimus 55 Cethrin 55 L BLP# 55 SNALP 55 nucleoside analogs 55 Cardio Vascu Grow 55 PEGPH# 55 Junovan TM 55 UPLYSO 55 midstage trials 55 Epothilones 55 NGX# 55 MediVas 55 SIR Spheres 55 SAR# [004] 55 pertuzumab 55 Mipomersen 55 methylnaltrexone 55 AAV vector 55 BioSTAR R 55 Leukine ® 55 anti CD3 55 LY# [003] 55 IMC #B 55 oral gallium 55 Ereska 55 ONTAK 55 Flutiform TM 55 IV Busulfex 55 immunomodulatory 55 Hedgehog Pathway Inhibitor 55 Iloperidone 55 Hsp# inhibition 55 Plenaxis TM 55 MOR# 55 Diamyd ® 55 vidofludimus 55 Ruconest 55 molecular entities NMEs 55 A3 adenosine receptor 55 PRX# 55 AKT inhibitor 55 PREOS R 55 omega interferon 55 ocular formulation 55 adipiplon 55 Xcellerated T Cells 55 dacetuzumab 55 ONCONASE R 55 ixabepilone 55 prodrugs 55 Rescula 55 torezolid phosphate 55 targeting CD# 55 Phase IIa trials 55 oral anticancer 55 JAK inhibitors 55 Elotuzumab 55 Hsp# Inhibitor 55 humanized antibody 55 EOquin 55 WILEX 55 TLR antagonists 55 ganaxolone 55 TRIOLEX 55 Vernakalant 55 Dapagliflozin 55 Mitoxantrone 55 trabectedin 55 Alpharadin 55 MGCD# [002] 55 IV APAP 55 Vandetanib 55 vorinostat 55 confirmatory Phase III 55 novel VDA molecule 55 cobiprostone 55 Phase #b/#a trial 55 Exelixis compounds 55 PEP# [003] 55 Eligard ® 55 NeuroVax TM 55 zanolimumab 55 granulated mesalamine 55 ICA # 55 velafermin belinostat 55 Thalomid ® 55 autoimmune indications 55 LentiVector technology 55 Campath ® 55 Ophena 55 Zemiva TM Trofex TM 55 ITAX 55 synthetic siRNA 55 Perifosine 55 Urocidin 55 bardoxolone 55 Ceflatonin 55 ulimorelin 55 Viprinex 55 MEK inhibitor RDEA# 55 Adentri 55 radiolabeled TM# 55 immatics 55 Myolimus 55 Fx #A 55 IoGen 55 humanized monoclonal antibodies 55 Cloretazine 55 HuMax TAC 55 GLPG# 55 small molecule defensin 55 rThrombin 55 humanized antibodies 55 CG# [003] 55 Valortim R 55 GGF2 55 Oracea TM 55 intravesical infusion therapy 55 romidepsin 55 pivotal bioequivalence 55 Ozarelix 55 ANYARA 55 MGd 55 Marketing Authorisation Application 55 phase IIb trial 55 therapeutic antibody 55 drug conjugate 55 custirsen 55 Fentanyl Taifun 55 recombinant biopharmaceutical 55 nanoviricide 55 Ocrelizumab 55 immune modulating 55 Egrifta 55 forodesine 55 SMT C# 55 cartilage regeneration 55 ALN HTT 55 Nanobody 55 Nanobody ® 55 Virulizin ® 55 acyclovir Lauriad ® 55 BLP# Liposome Vaccine 55 cytotoxic 54 Nebido 54 ridaforolimus 54 Nuvion 54 ABRAXANE ® 54 Phase Ib II 54 Phase 1b trial 54 Hycamtin 54 Vasovist 54 APD# 54 picoplatin 54 SinuNase 54 MLN# 54 non nucleoside HCV 54 Annamycin 54 oral ridaforolimus 54 anti CD3 monoclonal 54 budesonide foam 54 Axiogenesis 54 Hemospan 54 NB S# strontium malonate 54 MyVax 54 Vidaza azacitidine 54 LY# [002] 54 ATL# [002] 54 BiTE R 54 GRN# 54 ospemifene 54 cGMP manufacture 54 Omigard 54 hyaluronidase rHuPH# 54 OMP #R# 54 telomerase therapeutic 54 Vitaxin 54 SparVax ™ 54 HuMax EGFr 54 Zensana 54 Chemokine Therapeutics 54 RH1 54 GelSite polymer 54 OraTest R 54 overactive bladder AA# 54 novel histone deacetylase 54 anti angiogenic drugs 54 Onsolis 54 BeneFIX 54 Factor Xa inhibitor 54 NTDDS 54 FUSILEV ® 54 RAV# 54 MBP# [001] 54 GLP toxicology 54 oncolytic virus therapies 54 NovaBay Aganocide compounds 54 ImmunoVEX HSV2 54 Targretin 54 CRD5 54 intranasal formulation 54 Xinlay 54 ALN TTR 54 oral proteasome inhibitor 54 Lixivaptan 54 ViaCyte 54 OncoGel 54 Sulonex 54 KRYSTEXXA TM pegloticase 54 proteasome inhibitors 54 CTLA4 Ig 54 markets HP Acthar 54 anticancer agent 54 Lymphoseek ® 54 ZK EPO 54 lenalidomide Revlimid R 54 Initiate Clinical Trial 54 Apoptone 54 mapatumumab 54 SILENOR 54 alkylating agent 54 clinical trials 54 selective immunoproteasome inhibitor 54 2 methoxyestradiol 54 NEUGENE 54 Sphingomab 54 Silodosin 54 midstage studies 54 BUPHENYL R 54 bortezomib Velcade 54 oritavancin 54 Corlux 54 decitabine 54 Liprotamase 54 BiovaxID TM 54 RNA antagonist 54 rasagiline tablets 54 romazarit 54 thymalfasin 54 MORAb 54 anticancer activity 54 Traficet EN 54 atrasentan 54 FACTIVE tablets 54 StaphVAX R 54 cetuximab Erbitux R 54 VA# [002] 54 celgosivir 54 Carfilzomib 54 humanized anti 54 velafermin 54 axitinib 54 Anticalins R 54 rNAPc2 54 cysteamine bitartrate 54 docetaxel Taxotere ® 54 orally administered inhibitor 54 Triapine R 54 Sanochemia 54 CINOD 54 hyperimmune products 54 topical formulations 54 Troxatyl 54 R#/MEM # 54 recombinant protein 54 recombinant antibodies 54 luliconazole 54 palifosfamide 54 oncology indications 54 Camvia 54 alagebrium 54 LBH# 54 selective inhibition 54 Vivecon 54 Tamibarotene 54 Orally administered 54 Thrombin 54 ALN RSV# 54 novel therapeutic antibodies 54 lintuzumab SGN 54 Kuvan TM sapropterin 54 Elagolix 54 #D#C# 54 butyrylcholinesterase 54 Fc fusion protein 54 ATPace 54 Degarelix 54 potent antiproliferative 54 Tarvacin TM 54 Opterone 54 PRX # 54 Bezielle 54 Phase Ib 54 Locteron ® 54 epigenetic therapies 54 IMP# 54 TRISENOX ® 54 Ketotransdel 54 Intravenous Human 54 valopicitabine 54 Linjeta TM 54 myelofibrosis polycythemia vera 54 HDACi 54 ruxolitinib 54 ASONEP 54 DepoDur TM 54 INTERCEPT platelets 54 menadione 54 Genz # 54 telaprevir VX 54 PBT2 54 Quinamed 54 KSP inhibitor 54 vascular disrupting agent 54 vernakalant oral 54 Mycophenolate Mofetil 54 Vaxfectin 54 HepaGam B TM 54 Telintra 54 generation antisense 54 lumiliximab 54 Neurodex 54 VNP#M 54 PANVAC VF 54 Memryte 54 small molecule tyrosine 54 Pirfenidone 54 Phase Ib clinical trials 54 Kahalalide F 54 ongoing Phase 1b 54 ATL/TV# 54 GelVac 54 uric acid lowering 54 vismodegib 54 non nucleoside 54 Cerimon 54 NP2 Enkephalin 54 metabolite identification 54 MVA BN 54 ibudilast 54 Zemplar Capsules 54 pancreatic enzyme replacement 54 Abiraterone 54 Voreloxin 54 Altastaph 54 GPR# agonists 54 investigational immunotherapy 54 Vorinostat 54 Tarvacin 54 VALOR trial 54 FluCide 54 PNT# 54 FACTIVE R gemifloxacin 54 Loramyc R 54 eltrombopag 54 Alnylam #x# 54 multicenter Phase II 54 Frova ® 54 Celator 54 DU #b 54 novel anti infective 54 Transdel TM 54 budiodarone 54 pralatrexate injection folate analogue 54 Phase IIb trials 54 DermaVir Patch 54 EOquin TM 54 mGluR2 NAM 54 SECTA therapy 54 MYCAMINE 54 YONDELIS R 54 REMOXY R 54 therapeutically relevant 54 MCSP respectively 54 NV1FGF 54 Hybridon 54 TLR9 agonist 54 tolperisone 54 recurrent metastatic ovarian cancer 54 IMiDs R 54 inhaled formulation 54 ENRICH trial 54 Combidex 54 Sanvar R 54 fibrotic disease 54 PMA submission 54 Tumour Vascular Disrupting Agent 54 Shigamabs ® 53 angiogenesis inhibitor 53 sublingual tablets 53 Neo Kidney Augment ™ 53 histone deacetylase inhibitor 53 antiangiogenic activity 53 Elafin 53 hoFH 53 Relivar 53 JZP 6 53 Generx ™ 53 GPR# agonist 53 INT# [002] 53 Vectibix panitumumab 53 RNAi therapeutic 53 Selective Electrochemical Tumor Ablation 53 JAK1 53 topically applied SEPA 53 Anticalin ® 53 leading oral taxane 53 delipidation 53 HER2 positive metastatic breast 53 Sular formulation 53 COPREXA 53 Anturol TM 53 Icatibant 53 glufosfamide 53 Pemetrexed 53 Xenazine ® 53 PRECISE Trial 53 ESBA# 53 ZEGERID Capsules 53 glucokinase activator 53 IgG1 monoclonal antibody 53 TRAIL receptor antibodies 53 antibody fragment 53 XL# XL# XL# 53 investigational pan BCR 53 adecatumumab MT# 53 INS# [001] 53 Soliris TM eculizumab 53 samalizumab 53 AMD# [003] 53 OLpur TM H2H 53 protein kinase inhibitor 53 Cutanea 53 modified glutathione analog 53 Reolysin 53 FENTORA 53 XP# XP# 53 ZFP Therapeutic 53 IND CTA 53 Apaziquone 53 NexACT 53 muscarinic receptor agonist 53 dasatinib Sprycel 53 ReN# 53 DepoVax TM 53 successfully commercialize Iluvien 53 regenerative medicine therapies 53 GSK# [002] 53 generation purine nucleoside 53 thalidomide Thalomid 53 QRxPharma